| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166592 Antiinflammatory agents |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166582 Administering stachyose to treat atopic dermatitis; can be added to medicine, food and beverage |
| 01/23/2007 | US7166568 Compositions and methods to inhibit formation of the C5b-9 complex of complement |
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/23/2007 | US7166455 A genetic engineered nuclear acids, culturing Bacteroides fragilis, encoding immunomodulator, treating inflammatory bowel disease |
| 01/23/2007 | US7166298 Genetic immunization with cationic lipids |
| 01/23/2007 | US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
| 01/23/2007 | US7166291 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/23/2007 | US7166285 Anti-IL-12 antibodies and compositions |
| 01/23/2007 | US7166283 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 01/23/2007 | CA2326389C Novel cd19xcd3 specific polypeptides and uses thereof |
| 01/23/2007 | CA2206754C Benzimidazole derivatives with antihistaminic activity |
| 01/23/2007 | CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof |
| 01/18/2007 | WO2007008016A1 A compound comprising prodigiosin isolated from serratia marcescence b-1231 kctc 0386bp for provention and treatment of acute graft-versus-host disease |
| 01/18/2007 | WO2007007919A2 Heterocyclic janus kinase 3 inhibitors |
| 01/18/2007 | WO2007007851A1 Percutaneously absorptive ophthalmic preparation comprising epinastine |
| 01/18/2007 | WO2007007778A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2007007562A1 Polysaccharide produced by microorganism belonging to genus bifidobacterium |
| 01/18/2007 | WO2007007145A2 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 01/18/2007 | WO2006125117A3 Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component |
| 01/18/2007 | WO2006113308A8 Method for treating inflammatory bowel disease (ibd) by an anti-cd20 antibody |
| 01/18/2007 | WO2006100635A3 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 01/18/2007 | WO2006086361A3 ANTILYMPHOCYTE ANTIBODY INDUCTION BY COMBINATION OF AN SlP RECEPTOR AGONIST/MODULATOR AND OF IMMUNOSUPPRESSIVE DRUGS |
| 01/18/2007 | WO2006073748A3 Antibodies against antigen presenting cells and uses thereof |
| 01/18/2007 | WO2004084837A3 Methods and compositions for treating and preventing inflammatory conditions |
| 01/18/2007 | WO2004071468A3 Short immunomodulatory oligonucleotides |
| 01/18/2007 | US20070015772 Nucleoside metabolism inhibitors |
| 01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015258 Alpha-beta C4BP -type recombinant heteromultimeric proteins |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 01/18/2007 | US20070014809 B Cell Activation and Polypeptides Having CD14 Activity |
| 01/18/2007 | US20070014785 Use of antibodies against CD20 for the treatment of the graft versus host disease |
| 01/18/2007 | US20070014737 Administering quinine, chlorzoxazone, cyclobenzaprine, carisoprodol via vaporization |
| 01/18/2007 | CA2621359A1 Polysaccharide produced by microorganism belonging to genus bifidobacterium |
| 01/18/2007 | CA2615291A1 Heterocyclic janus kinase 3 inhibitors |
| 01/18/2007 | CA2614314A1 Human anti-madcam antibodies |
| 01/18/2007 | CA2614147A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | CA2613017A1 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 01/18/2007 | CA2612506A1 Methods of treatment using hydroquinone ansamycins |
| 01/18/2007 | CA2611607A1 Indolylmaleimide derivatives |
| 01/17/2007 | EP1743944A1 Novel method of screening |
| 01/17/2007 | EP1743941A1 Novel mite allergen |
| 01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
| 01/17/2007 | EP1743657A2 Stabilisation of macrolides |
| 01/17/2007 | EP1743651A1 Vaccine compositions which are obtained from streptomyces |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
| 01/17/2007 | EP1742916A1 Phenyl compounds and their use in the treatment of conditions mediated by the action of pge2 at the ep1 receptor |
| 01/17/2007 | EP1742649A1 Active ingredient complex of seaweed plants, especially the zosteraceae family, method for the production thereof, and use of the same |
| 01/17/2007 | EP1742640A2 Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| 01/17/2007 | EP1742633A2 Use of c-kit inhibitors for treating fibrosis |
| 01/17/2007 | EP1432445B1 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |
| 01/17/2007 | EP1399480B1 Multimers of class i major histocompatibility complexes containing modified beta2-microglobulin proteins |
| 01/17/2007 | EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1272160B1 Lipid-based drug delivery systems for topical application |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
| 01/17/2007 | EP1185299B1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 01/17/2007 | EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 01/17/2007 | EP1086207B1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 01/17/2007 | EP1076704B1 Il-2 selective agonists and antagonists |
| 01/17/2007 | CN1898267A 修饰的抗cd52抗体 Modified anti-cd52 antibody |
| 01/17/2007 | CN1897968A Method of treatment using interferon-tau |
| 01/17/2007 | CN1897966A Therapeutic regimens for baff antagonists |
| 01/17/2007 | CN1897953A Anti-inflammatory agents |
| 01/17/2007 | CN1897948A Alkoxy substituted imidazoquinolines |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
| 01/17/2007 | CN1895673A The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1895545A Glossy ganoderma spore essential oil compound capsules and preparation thereof |
| 01/17/2007 | CN1895451A Medicinal composition for treating hives and eczema and its preparation |
| 01/17/2007 | CN1895409A Medicinal decoction for treating intractable hives and its preparation |
| 01/17/2007 | CN1895313A Extraction of total saponin from ginseng or American ginseng stem/leaf and its product |
| 01/17/2007 | CN1895306A Medicinal food for treating hives and its preparation |
| 01/17/2007 | CN1895296A Inspection for lucid ganoderma product oral preparation quality |
| 01/17/2007 | CN1895287A Medicine with antibacterial, antiviral, anticancer, antineoplastic, antianaphylaxis and anti-deficit functions |
| 01/17/2007 | CN1895266A Compound slow-releasing immune enhancer for cock |
| 01/17/2007 | CN1895261A Use of pokeroot saponin A in preparation medicine for treating rheumatoid arthritis |
| 01/17/2007 | CN1895255A Archaeus-agent capsules and production thereof |
| 01/17/2007 | CN1895091A Production of tremella gel |
| 01/17/2007 | CN1895066A Anti-body leben tablet (powder) |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/16/2007 | US7164000 RANTES mutants and therapeutic applications thereof |
| 01/16/2007 | US7163960 Treatment and prevention of inflammatory disorders |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163926 enhancing efficacy of a DNA plasmid vaccine which comprises a naked DNA containing and expressing in vivo a heterologous polynucleotide, an immunogen of equine rhinopheumonia virus, by adding to the DNA plasmid vaccine an adjuvant which is a polymer of acrylic or methacrylic acid |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163702 Process for isolating sea cucumber saponin Frondoside A, and immunomodulatory methods of use |
| 01/16/2007 | US7163683 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |